US-based pharma data analytics provider Diaceutics has appointed former Kantar Health exec Yvanka Gilliam as Vice President of Operations, Asia Pacific (APAC).

Diaceutics claims to have built the world's largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries. Gilliam (pictured) joins from Kantar Health, where she served as a Senior Client Partner, Real World Evidence, developing and implementing global business planning strategies and conducted research. She has also worked with IQVIA Asia Pacific in the Real World Insights Division, and as a Senior Medical Science Liaison at AstraZeneca Pharmaceutical Corporation.

In her new role, Gilliam will be responsible for managing business development and operations across the APAC region, with a focus on establishing collaborations and partnerships to drive growth and revenue. Her role will also include identifying new services and solutions for the company's platform, DXRX, and increase the offering.

CEO Peter Keeling comments: 'Yvanka's appointment will strengthen Diaceutics' credentials as the market leader in the development and commercialization of precision medicine diagnostics. As her twenty-plus year career in pharma has been focused primarily on the research and development of innovative oncology compounds, Yvanka is firmly aligned with Diaceutics' goal to bridge the gap between diagnostics and therapeutic decision-making in order to improve testing outcomes for patients and enable better access to the right drug at the right time.'

Web site: www.diaceutics.com .

• Printer-friendly version of this article.
• Email this article to a friend.